z-logo
open-access-imgOpen Access
Pioglitazone hydrochloride
Author(s) -
Yathirajan Hemmige S.,
Nagaraj Basavegowda,
Nagaraja Padmarajaiah,
Bolte Michael
Publication year - 2005
Publication title -
acta crystallographica section e
Language(s) - English
Resource type - Journals
ISSN - 1600-5368
DOI - 10.1107/s1600536804033100
Subject(s) - pioglitazone , hydrochloride , medicine , chemistry , endocrinology , diabetes mellitus , type 2 diabetes , organic chemistry
The title compound [systematic name: ()‐5‐({4‐[2‐(5‐ethyl‐2‐pyridinio)ethoxy]phenyl}methyl)thiazolidine‐2,4‐dione chloride], C 19 H 21 N 2 O 3 S + ·Cl − , is an oral antidiabetic agent. In the crystal structure, the molecules are linked by N—H⋯Cl hydrogen bonds into chains.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom